Abstract
Tenascin serum levels were evaluated in 118 patients with primary colorectal carcinoma and in a control group of 51 healthy persons in a double-sided sandwich ELISA. The data were correlated with post-operative TNM-staging. Patients with colorectal carcinomas had significantly higher serum levels of tenascin than the control group. At the 95% level of specificity, sensitivity was 25%. Tumor grading obviously had no influence on the level of tenascin in serum. With increasing pT-category, tenascin levels increased as well. In patients with distant metastatic disease, serum tenascin levels were significantly higher than in patients without distant metastases. These data suggest that, in colorectal carcinoma, the preoperative level of serum tenasin reflects the total tumor burden and correlates with metastatic disease. Our observation warrants a prospective study of the relevance of tenascin serum levels with regard to prognosis and as an indicator of relapse.
References
Oct 1, 1992·Japanese Journal of Cancer Research : Gann·H KawakatsuT Sakakura
Aug 1, 1992·Gastroenterology·S E RiedlP Möller
Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·L BorsiL Zardi
Jan 1, 1990·Annals of the New York Academy of Sciences·V A LightnerH P Erickson
Nov 1, 1990·Neuron·A Faissner, J Kruse
Apr 1, 1991·International Journal of Cancer. Journal International Du Cancer·P G NataliL Zardi
Jun 1, 1991·The Journal of Cell Biology·A LochterA Faissner
Jul 1, 1987·The Journal of Cell Biology·E AufderheideP Ekblom
Dec 1, 1988·The Journal of Cell Biology·E Aufderheide, P Ekblom
Dec 1, 1988·The Journal of Cell Biology·E J MackieD Liverani
Jan 1, 1989·Annual Review of Cell Biology·H P Erickson, M A Bourdon
Oct 15, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·K WashizuK Takeuchi
May 1, 1993·British Journal of Cancer·T SakaiM Saito
Sep 1, 1993·The Journal of Surgical Research·T ShojiS Morii
Citations
Jul 15, 1999·International Journal of Cancer. Journal International Du Cancer·M DueckA Faissner
Sep 29, 1995·Experientia·R Chiquet-Ehrismann
Mar 24, 1998·Diseases of the Colon and Rectum·S RiedlA Faissner
Feb 29, 2000·Clinical Biochemistry·T RopersM Gehrmann
Jun 10, 2004·The Journal of Trauma·Heikki T WiikKari A Haukipuro
Feb 4, 1998·Journal of Cutaneous Pathology·H TuominenM Kallioinen
Jan 16, 2007·World Journal of Surgery·Akihiko TakedaIsamu Koyama
Mar 28, 2009·Journal of Cancer Research and Clinical Oncology·Petra RichterAlexander Berndt
Nov 27, 1995·International Journal of Cancer. Journal International Du Cancer·S SchienkC Rüegg
Sep 3, 2003·Clinical and Experimental Dermatology·E R BurchardtA K Bosserhoff
Feb 29, 2008·International Journal of Cancer. Journal International Du Cancer·Martin DegenWalter Seelentag
Nov 24, 2012·Proteomics·Astrid De BoeckOlivier De Wever
Dec 21, 2012·Journal of Internal Medicine·A Santamaria-Martínez, J Huelsken
Dec 9, 2014·Cell Adhesion & Migration·Sean P Giblin, Kim S Midwood
Apr 4, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·D TastekinS Vatansever
Apr 12, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Tastekin DidemKaynur Oznur
Mar 17, 1999·Molecular Carcinogenesis·J M González-SanchoA Muñoz
Oct 5, 2002·Journal of Helminthology·P SithithawornT Sakakura
Jan 17, 2008·Oncology·M LundinC Haglund
Jul 17, 1997·International Journal of Cancer. Journal International Du Cancer·B SchnyderB F Odermatt
Jul 14, 2011·Lab on a Chip·Anja SteudeOliver Pänke
Oct 13, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sabrina HundtHermann Brenner